Cover Image
市場調查報告書

Neuroptis Biotech:產品平台分析

Neuroptis Biotech - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256052
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
Neuroptis Biotech:產品平台分析 Neuroptis Biotech - Product Pipeline Review - 2015
出版日期: 2015年11月18日 內容資訊: 英文 21 Pages
簡介

Neuroptis Biotech 是總公司設立在法國巴黎的生物科技企業。該公司開發,提供眼科用治療藥和臨床實驗實施計劃書。該公司產品,有眼球乾燥症候群、角膜水腫、前葡萄膜炎的治療、玻璃體液內注射的後葡萄膜炎及雙邊視神經乳頭水腫的治療等。

本報告提供Neuroptis Biotech的治療藥開發平台的現狀及最新更新的各開發階段比較分析、企業和研究機關最新的新聞和發表、正在開發的治療藥、治療藥的評估、後期階段及中止的計劃相關資訊等。

Neuroptis Biotech的基本資料

  • Neuroptis Biotech概要
  • 主要資訊
  • 企業資料

Neuroptis Biotech :R&D概要

  • 主要的治療範圍

Neuroptis Biotech :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Neuroptis Biotech :開發中產品概況

  • 初期階段的開發中產品
    • 在前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Neuroptis Biotech :藥物簡介

  • NOP-3
  • NOP-5
  • NOP-2
  • NOP-4

Neuroptis Biotech :開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Neuroptis Biotech :最近的開發平台趨勢

Neuroptis Biotech :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07785CDB

Summary

Global Markets Direct's, 'Neuroptis Biotech - Product Pipeline Review - 2015', provides an overview of the Neuroptis Biotech's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Neuroptis Biotech's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Neuroptis Biotech including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Neuroptis Biotech's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Neuroptis Biotech's pipeline products

Reasons to buy

  • Evaluate Neuroptis Biotech's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Neuroptis Biotech in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Neuroptis Biotech's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Neuroptis Biotech and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Neuroptis Biotech
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Neuroptis Biotech and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Neuroptis Biotech Snapshot
    • Neuroptis Biotech Overview
    • Key Information
    • Key Facts
  • Neuroptis Biotech - Research and Development Overview
    • Key Therapeutic Areas
  • Neuroptis Biotech - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Neuroptis Biotech - Pipeline Products Glance
    • Neuroptis Biotech - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Neuroptis Biotech - Drug Profiles
    • NOP-3
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NOP-5
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • NOP-4
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Neuroptis Biotech - Pipeline Analysis
    • Neuroptis Biotech - Pipeline Products by Target
    • Neuroptis Biotech - Pipeline Products by Route of Administration
    • Neuroptis Biotech - Pipeline Products by Molecule Type
    • Neuroptis Biotech - Pipeline Products by Mechanism of Action
  • Neuroptis Biotech - Recent Pipeline Updates
  • Neuroptis Biotech - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Neuroptis Biotech, Key Information
  • Neuroptis Biotech, Key Facts
  • Neuroptis Biotech - Pipeline by Indication, 2015
  • Neuroptis Biotech - Pipeline by Stage of Development, 2015
  • Neuroptis Biotech - Monotherapy Products in Pipeline, 2015
  • Neuroptis Biotech - Preclinical, 2015
  • Neuroptis Biotech - Discovery, 2015
  • Neuroptis Biotech - Pipeline by Target, 2015
  • Neuroptis Biotech - Pipeline by Route of Administration, 2015
  • Neuroptis Biotech - Pipeline by Molecule Type, 2015
  • Neuroptis Biotech - Pipeline Products by Mechanism of Action, 2015
  • Neuroptis Biotech - Recent Pipeline Updates, 2015

List of Figures

  • Neuroptis Biotech - Pipeline by Top 10 Indication, 2015
  • Neuroptis Biotech - Pipeline by Stage of Development, 2015
  • Neuroptis Biotech - Monotherapy Products in Pipeline, 2015
  • Neuroptis Biotech - Pipeline by Top 10 Route of Administration, 2015
  • Neuroptis Biotech - Pipeline by Top 10 Molecule Type, 2015
Back to Top